Your browser doesn't support javascript.
loading
Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
Ettinger, David S; Wood, Douglas E; Aisner, Dara L; Akerley, Wallace; Bauman, Jessica R; Bharat, Ankit; Bruno, Debora S; Chang, Joe Y; Chirieac, Lucian R; D'Amico, Thomas A; DeCamp, Malcolm; Dilling, Thomas J; Dowell, Jonathan; Gettinger, Scott; Grotz, Travis E; Gubens, Matthew A; Hegde, Aparna; Lackner, Rudy P; Lanuti, Michael; Lin, Jules; Loo, Billy W; Lovly, Christine M; Maldonado, Fabien; Massarelli, Erminia; Morgensztern, Daniel; Ng, Thomas; Otterson, Gregory A; Pacheco, Jose M; Patel, Sandip P; Riely, Gregory J; Riess, Jonathan; Schild, Steven E; Shapiro, Theresa A; Singh, Aditi P; Stevenson, James; Tam, Alda; Tanvetyanon, Tawee; Yanagawa, Jane; Yang, Stephen C; Yau, Edwin; Gregory, Kristina; Hughes, Miranda.
Affiliation
  • Ettinger DS; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
  • Wood DE; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance.
  • Aisner DL; University of Colorado Cancer Center.
  • Akerley W; Huntsman Cancer Institute at the University of Utah.
  • Bauman JR; Fox Chase Cancer Center.
  • Bharat A; Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
  • Bruno DS; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.
  • Chang JY; The University of Texas MD Anderson Cancer Center.
  • Chirieac LR; Dana-Farber/Brigham and Women's Cancer Center.
  • D'Amico TA; Duke Cancer Institute.
  • DeCamp M; University of Wisconsin Carbone Cancer Center.
  • Dilling TJ; Moffitt Cancer Center.
  • Dowell J; UT Southwestern Simmons Comprehensive Cancer Center.
  • Gettinger S; Yale Cancer Center/Smilow Cancer Hospital.
  • Grotz TE; Mayo Clinic Cancer Center.
  • Gubens MA; UCSF Helen Diller Family Comprehensive Cancer Center.
  • Hegde A; O'Neal Comprehensive Cancer Center at UAB.
  • Lackner RP; Fred & Pamela Buffett Cancer Center.
  • Lanuti M; Massachusetts General Hospital Cancer Center.
  • Lin J; University of Michigan Rogel Cancer Center.
  • Loo BW; Stanford Cancer Institute.
  • Lovly CM; Vanderbilt-Ingram Cancer Center.
  • Maldonado F; Vanderbilt-Ingram Cancer Center.
  • Massarelli E; City of Hope National Medical Center.
  • Morgensztern D; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.
  • Ng T; The University of Tennessee Health Science Center.
  • Otterson GA; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.
  • Pacheco JM; University of Colorado Cancer Center.
  • Patel SP; UC San Diego Moores Cancer Center.
  • Riely GJ; Memorial Sloan Kettering Cancer Center.
  • Riess J; UC Davis Comprehensive Cancer Center.
  • Schild SE; Mayo Clinic Cancer Center.
  • Shapiro TA; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
  • Singh AP; Abramson Cancer Center at the University of Pennsylvania.
  • Stevenson J; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.
  • Tam A; The University of Texas MD Anderson Cancer Center.
  • Tanvetyanon T; Moffitt Cancer Center.
  • Yanagawa J; UCLA Jonsson Comprehensive Cancer Center.
  • Yang SC; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
  • Yau E; Roswell Park Comprehensive Cancer Center; and.
  • Gregory K; National Comprehensive Cancer Network.
  • Hughes M; National Comprehensive Cancer Network.
J Natl Compr Canc Netw ; 20(5): 497-530, 2022 05.
Article de En | MEDLINE | ID: mdl-35545176
ABSTRACT
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Small Cell Lung Cancer (NSCLC) provide recommended management for patients with NSCLC, including diagnosis, primary treatment, surveillance for relapse, and subsequent treatment. Patients with metastatic lung cancer who are eligible for targeted therapies or immunotherapies are now surviving longer. This selection from the NCCN Guidelines for NSCLC focuses on targeted therapies for patients with metastatic NSCLC and actionable mutations.
Sujet(s)

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Carcinome pulmonaire non à petites cellules / Tumeurs du poumon Type d'étude: Diagnostic_studies / Guideline Limites: Humans Langue: En Journal: J Natl Compr Canc Netw Sujet du journal: NEOPLASIAS Année: 2022 Type de document: Article

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Carcinome pulmonaire non à petites cellules / Tumeurs du poumon Type d'étude: Diagnostic_studies / Guideline Limites: Humans Langue: En Journal: J Natl Compr Canc Netw Sujet du journal: NEOPLASIAS Année: 2022 Type de document: Article
...